Prediction of significant liver fibrosis in a health examination population using a random forest model
BACKGROUNDLiver fibrosis is a critical stage in chronic liver disease progression, and early identification of high-risk individuals is essential.However, FibroTouch, although noninvasive, is expensive and not widely accessible for large-scale screening.AIM To develop and validate a machine learning model using routine clinical indicators to predict ≥ F2 fibrosis in health examination populations.METHODS This retrospective multicenter cross-sectional diagnostic-prediction study included a single-center cohort of 13899 participants from the First Affiliated Hospital of Zhejiang University School of Medicine (June 2021 to August 2025).The development cohort was randomly split 8:2 into training (n = 11119) and internal validation (n = 2780) sets.The tuned original model was recalibrated using a later same-hospital cohort (n = 2363; September 2025 to July 2026).Both original and recalibrated models underwent independent geographic external validation at Sichuan Provincial People's Hospital (n = 309). RESULTSSix clinical variables (body mass index, fasting insulin, alanine aminotransferase, waist circumference, triglycerides, and cholinesterase) were selected.The random forest (RF) model achieved an area under the curve (AUC) of 0.846 [95% confidence interval (CI): 0.806-0.885]and Brier score of 0.032 (95%CI: 0.028-0.037),significantly outperforming all traditional scores.Calibration was satisfactory, and decision curve analysis confirmed net clinical benefit.In the temporal cohort, the original model showed an AUC of 0.766 4 / 42 (95%CI: 0.713-0.815)and was subsequently recalibrated.In the independent geographic external validation cohort from Sichuan Province, the original and recalibrated models achieved AUCs of 0.718 (95%CI: 0.565-0.844)and 0.718 (95%CI: 0.565-0.844),respectively.Subgroup analyses showed consistent performance across age, sex, and comorbidities. CONCLUSIONThis six-indicator RF model offers an inexpensive, effective screening tool for significant liver fibrosis in Chinese individuals; however, the results should be interpreted cautiously as the reference was FibroTouch, not biopsy.
Authors
- Piaopiao Jin (ORCID: https://orcid.org/0000-0002-2220-8959)
- Liu Chen-bing
- Xu Wei-Wei
- Dongyu Li (ORCID: https://orcid.org/0000-0001-7581-0276)
- Qi Sun
- Feng Zhang
- Nan Li
- Zhong Liu
- Chao Shen
- Li-Hong Qiu
Institutions
- University Medical Center Groningen (NL)
- National University of Singapore (SG)
- National University Health System (SG)
- First Affiliated Hospital Zhejiang University (CN)
- Zhejiang University (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3748/wjg.124330
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00